Constellation Software gets $1000 price target at Echelon Wealth

Record revenue growth and key acquisitions are cause for a revaluation of Constellation Software Inc. (Constellation Software Stock Quote, Chart, News: TSX:CSU), says Ralph Garcea of Echelon Wealth Partners, who has upgraded his rating from “Hold” to “Buy” and raised CSU’s target price from $800.00 to $1,000.00.

This week, diversified software company Constellation Software released its fourth quarter results for the period ending December 31, 2017, featuring a 22 per cent increase in revenue ($688 million as compared to $564 million in Q4 2016) and an adjusted EBITA increase of 15 per cent to $175 million.

Those attractive numbers combine with some key acquisitions of late, including Quebec-based Acceo Solutions Inc., through its wholly-owned subsidiary N. Harris Computer Corp., announced in January.

Garcea sees a number of positives running through CSU, including having a diversified set of products matched with a diversified, global customer base (where the company boasts a greater than 92 per cent retention rate), highly predictable revenue and great capital allocators, according to Garcea.

“Deal metrics need to have ROICs of >30% to get evaluated. We believe ROICs will trend lower over time, but still remain over 30%,” says the analyst in a note to clients on Thursday. “CSU has ~80 ‘portfolio managers’ looking at deals with autonomy to do deals valued under $20M. Anything over $20M gets extra scrutiny from head office. We expect deal flow to increase, and to expand across geographies,” he says.

“On C2018E, CSU is trading at an EV/Sales of 4.7x and EV/EBITDA of 18.0x, versus the Global Software comparables at 6.2x and 21.5x, respectively,” says the analyst.

Garcea upgrades his “Hold” rating to a “Buy” and raises his DCF-based target to $1,000.00, representing a projected return of 19.6 per cent at time of publication.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: csu
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Héroux-Devtek is a buy, Desjardins says

Ahead of the company's quarterly results, Desjardins Securities analyst Benoit Poirier likes what he sees from Héroux-Devtek (Héroux-Devtek Stock Quote,… [Read More]

20 mins ago

JUSH stock is a buy, Beacon says

With its first quarter results on deck, Beacon Securities analyst Russell Stanley thinks Jushi Holdings (Jushi Holdings Stock Quote, Chart,… [Read More]

19 hours ago

Is Curaleaf stock still a buy?

The stock has been a steady climber since last October, but ahead of earnings is Curaleaf (Curaleaf Stock Quote, Chart,… [Read More]

22 hours ago

OpenText price target cut at National Bank

Following third quarter results he describes as "in-line", National Bank Financial analyst Richard Tse has cut his price target on… [Read More]

23 hours ago

Silicon Motion stock still a buy, Roth says

Following the company's first quarter results, Roth MKM analyst Suji Desilava remains bullish on Silicon Motion Technology (Silicon Motion Technology… [Read More]

23 hours ago

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

4 days ago